Harlow, United Kingdom

Helen Anne Willy

This inventor holds 4 USPTO granted patents. Top assignee: Glaxo Group Limited. Active years: 2009-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helen Anne Willy. Retrieved from https://idiyas.com/inventor/helen-anne-willy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Helen Anne Willy

Introduction

Helen Anne Willy is a notable inventor based in Harlow, GB. She has made significant contributions to the field of pharmaceuticals, holding a total of four patents. Her work focuses on developing innovative oral dosage forms for controlled drug release, which has important implications for patient care and medication efficacy.

Latest Patents

Among her latest patents is an oral dosage form designed for controlled drug release. This invention aims to improve the delivery and effectiveness of pharmaceutical treatments. Additionally, she has developed a pharmaceutical tablet that further enhances the options available for medication administration.

Career Highlights

Helen is currently employed at Glaxo Group Limited, a leading company in the pharmaceutical industry. Her role involves research and development, where she applies her expertise to create effective drug delivery systems. Her contributions have been instrumental in advancing the company's product offerings.

Collaborations

Helen has collaborated with several talented individuals in her field, including Wlodek Karolak and Chi Leung Li. These partnerships have fostered innovation and have led to the successful development of her patented technologies.

Conclusion

Helen Anne Willy's work exemplifies the impact of innovation in the pharmaceutical industry. Her patents and collaborations highlight her commitment to improving drug delivery systems, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…